Podophyllotoxin is a natural product endowed of a high antimitotic activity and a high affinity for tubulin. Its action results in the cessation of cell division, inducing cell death. However, its high toxicity restrains its use as drug. To overcome this drawback, several chemical modifications of the native podophyllotoxin have been made. However, to date, no reports have so far been directed toward incorporation of a metallocene moiety. The search for new organometallic drugs is a central field in drug discovery, including the domain of cancer therapy. In particular, metallocenyl moieties are known to increase or decrease, depending on the degree of conjugation in the organometallic motif, the selectivity of drugs toward cancer cells. The conjugate organometallic compound reduces the damage of healthy tissues, yet permitting the selective desired antimitotic and cytotoxic effects of the active principle. We report here the synthesis of ferrocene-containing podophyllotoxin analogs and preliminary antiproliferative tests.
Introduction
In the family of cyclolignans, podophyllotoxin (PPT), a pentacyclic aryl-tetralin lignan isolated from the roots and rhizomes of the American Mayapple (Podophyllum Peltatum) [1] ( Figure 1 , left), has attracted much attention as it has shown various biological activities among which an interesting antiproliferative effect. This antineoplastic activity arises from inhibition of tubulin polymerization [2] , a cytosolic protein required for the formation of the mitotic spindle. However, PPT exhibits a high toxicity and serious side effects like nausea, diarrhea, vomiting and damage to healthy tissue. Accordingly, its use is currently restricted to local treatments [3] . To overcome these drawbacks, several structure modification of podophyllotoxin have been performed on rings C (particularly the C-4 position), D and E, in view of obtaining more efficient and less toxic anticancer agents [4] . In particular, the two semi-synthetic derivatives, etoposide and teniposide [5] (Figure 1, right) , have emerged, and are now widely used drugs for chemotherapies in lung cancer, lymphomas and genital tumors [6] . Intriguingly enough, unlike their parent compound, these derivatives are not tubulin inhibitors, acting on topoisomerase II. Structure activity relationship (SAR) studies suggest that topoisomerase II inhibition activity is (among other requisite features) associated to the presence of a free 4'-hydroxy group [3a] . However, etoposide is associated with some issues such as drug resistance and poor bioavailability. Furthermore, picropodophyllin (PPP) ( Figure   1 , left), the C-2 epimer of PPT, although showing no activity against either tubulin or topoisomerase, displays inhibitory activity against tyrosine phosphorylation of Insulin-like Growth Factor 1 receptor (IGF-1R) [7] , which plays a crucial role in the transformation, growth, and survival of malignant cells. Due to the severe toxic effects of podophyllotoxin and its derivatives, the discovery of more potent and/or less toxic analogs of this family is highly desirable. Most of the PPT analogs have been prepared from the native molecule by functionalization of the 4-hydroxy group [8] .
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As a consequence, modifications of ring E have been to date only scarcely explored [9] . A modern strategy towards the modulation of biologically active products consists in the incorporation of an organometallic motif into the drug [10, 11] . Although organometallic compounds where used in therapy as early as the beginning of the 20 th century, this research field remained unexplored until 1996, when ferrocifen, a ferrocenyl analogue of tamoxifen, was reported , showing a high antiproliferative effect against two breast cancer cell lines:
MCF-7 and MDA-MB-231 [12] . The mechanism of action of ferrocifen on MCF-7 cells seems to be partly analogous to that of tamoxifen, i.e. an antagonist effect on α-type oestrogen receptors (ERα). Yet, MDA-MB-231 cells, lacking ERα, show resistance to tamoxifen and a strong antiproliferative effect with ferrocifens, which suggests that ferrocifen and tamoxifen here act through different ways. Further studies have shown that the ferrocenyl moiety, by virtue of its reversible redox behavior, induced oxidative stress in the cell, catalyzing production of reactive oxygen species (ROS) [13] . Since that breakthrough, other pharmaceuticals were modified in a similar manner, giving rise to new bioactive organometallic compounds [14] . An example of the above strategy is ferroquine, an innovative antimalarial drug, currently at Phase II clinical trial at Sanofi-Aventis [15] . Due to their peculiar properties, such as increased lipophilicity and bulkiness with respect to the original drugs, these new conjugates allow targeting of different sites in the biological medium. In line with the above concept, we envisioned to prepare ferrocenyl podophyllotoxin analogs, either via hemisynthesis, by simply esterifying the hydroxyl group at C-4 with the 
Results and discussion
Derivative 1 was straightforwardly obtained in 60% yield from native podophyllotoxin by treatment with ferrocenoyl chloride [16] , Et 3 N, and catalytic amount of DMAP (Scheme 1).
Scheme 1.
Esterification of native PPT with ferrocenoyl chloride.
The strategy to targets such as 2 is more complex and requires a multistep synthesis.
Accordingly, we decided to exploit a method we developed a few years ago [17] that gives access to the γ-oxo-ester key fragment A [18] (Scheme 2). This latter can be reached from the allylated β-dicarbonyl B via an intramolecular 6-exo Mizoroki-Heck coupling followed by alkene cleavage. B can result from a β-dicarbonyl derivative by allylation and alkylation with a ferrocenyl benzhydrol [19] such as C, which can in turn derive from piperonal and ferrocene. In particular, we reasoned that the benzhydrylation could be best achieved using
conditions favoring a S N 1 mechanism, [20] analogously to the benzhydrylation of active methlylenes pioneered by us some years ago [21] . Furthermore, S N 1-type nucleophilic substitutions on ferrocenyl derivatives are known to take place via iron assistance with retention of configuration [Error! Bookmark not defined.a-c]. As a consequence, control of the absolute configuration of the stereogenic center at the benzylic position might be a further bonus associated to this bioorganometallic approach. However, initially we focused our efforts only on the synthesis of racemic targets of type 2 lacking the lactone (D ring).
Scheme 2.
Retrosynthetic approach to the ferrocenyl analog of podophyllotoxin 2.
Benzhydrylic alcohol C was obtained via two alternative approaches from commercially available 6-bromopiperonal 3, namely, either an oxidation / Friedel-Crafts acylation / reduction sequence (Scheme 3, top) or a direct condensation with ferrocenyl lithium (Scheme 3, down). The former synthesis started with a Pinnick-type oxidation of aldehyde 3 to give the corresponding carboxylic acid 3' (85% y) by treatment with sodium chlorite in the presence of phosphoric acid [22] . After standard formation the corresponding acid chloride, FriedelCrafts acylation with ferrocene gave the diaryl ketone 3''. Finally, LiAlH 4 reduction gave alcohol C (47% y). This sequence suffered from low yields, including generation of some debrominated alcohol C' during the last reductive step [23] . The second, more straightforward, approach gave alcohol C in one step by reaction between ferrocenyl lithium [24] , and aldehyde 3 (44% y). Although the latter approach is the one recommended, the former route may be reconsidered for a future enantiopure synthesis [25] . yield [31] . Conversion of the methylidene into the key γ-oxo-ester A was then easily accomplished in 60% overall yield via osmium-catalyzed cis-dihydroxylation of 9 followed by NaIO 4 cleavage [32] . The acid form of the γ-oxo-ester derivative A, lacking the ferrocenyl tail, has already been identified as an advanced precursor to podophyllotoxin by Kende and coworkers,[18] who were able to obtain picropodophyllone by treatment with formaldehyde and NaOH [33] . Unfortunately, all attempts to further functionalize intermediate A, so as to add ring D, met with failure. Nevertheless, this study enabled us to have in hand a novel molecule incorporating rings A, B, and C of podophyllotoxin and carrying a ferrocenyl moiety in place of ring E. Accordingly, A (R = Et) was directly submitted to NaBH 4 reduction
[34], and the resulting alcohol 2 (R = Et) was sent for antiproliferative tests. [36] . An organometallic modification decreases its toxicity on fibroblasts and increases its selectivity on cancer cells. Compound 1 could be easier to use than podophyllotoxin. By contrast to 1, the alcohol 2 shows high IC 50 proving that 2 is much less active than 1. It is interesting to note that the organic moiety of 2 is different from podophyllotoxin molecule.
In the multitargeting ferrocifen series the cytotoxicity is mainly due so far to the redox primer {ferrocenyl-ene-phenol} producing ROS and able to delocalize the initial radical cation and generate electrophilic quinone methides at the mitochondrial level [14a] .When the ferrocenyl phenol species are unconjugated the anticancer effect decreases [37] . In the present case the organometallic motifs are different from this arrangement but this type of oxidative effect can be invoked to explain the results. The above redox ferrocifen motif is not unique in order to modulate the anticancer effects in a structure bearing a ferrocenyl group. Indeed, the recent literature reports other primers related to our original concept, producing similar effects in which the central electronic conduit in adjacent position to a ferrocenyl species is a naphtyl group or an ene-2,5-piperazinedione unit [38] . Unveiling such an effect expands our original discovery and may be of interest for future developments of organometallic antitumor species.
Conclusion
In this study we report the synthesis of two new podophyllotoxin analogs incorporating a ferrocenyl moiety and the preliminary antiproliferative tests of these conjugates on two breast cancer lines. While the former compound has been straightforwardly obtained by esterification between podophyllotoxin and ferrocenecarboxylic acid, the latter molecule, incorporating rings A, B and C of podophyllotoxin and carrying the ferrocenyl appendage in place of ring E of podophyllotoxin, required a 6-step synthesis starting from 6-bromopiperonal and ferrocene. Key steps in the synthesis were a challenging benzhydrylation generating a quaternary center, and an intramolecular Mizoroki-Heck reaction, which formed ring C of the target molecule. Such original structures have been discussed in terms of the importance of ferrocenyl conjugated motifs to generate antiproliferative effects.
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Experimental section
Reactions were carried out under argon atmosphere. All reagents were used as obtained from commercial suppliers. Dichloromethane and DMF were dried on a Braun purification system MB SPS-800. THF was distilled over sodium/benzophenone under nitrogen atmosphere. Thin layer chromatography was performed on Merck 60 F254 silica gel and revealed with an ultraviolet lamp (λ = 254 nm) and a staining reagent (KMnO 4 , vanillin or para-anisaldehyde).
Merck Geduran SI 60 silica gel (40-63 µm) was used for flash column chromatography. Synthesis and analytical data of some intermediates (3' and 3'') and by-products (C' and 7)
are described only in the SI. 
Ethyl 2-acetyl-2-((6-bromobenzo[1,3]dioxol-5-yl)(pherrocenyl)methyl)pent-4-enoate 5.
Starting 
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
NMR Spectra
